United States

Securities and Exchange Commission

Washington, D.C. 20549

 

Form N-Q


 

Quarterly Schedule of Portfolio Holdings of Registered

Management Investment Company

 

 

Investment Company Act file number: 811-05807

 

 

Eagle Capital Growth Fund, Inc.

(Exact name of registrant as specified in charter)

 

 

205 E. Wisconsin Ave, Suite 120, Milwaukee, WI 53202

(Address of principal executive offices) (zip code)

 

 

Luke E. Sims, President

Eagle Capital Growth Fund, Inc.

205 E. Wisconsin Ave

Suite 120

Milwaukee, WI 53202

(414) 765-1107

      (Name and address of agent for service)

 

 

Registrant’s telephone number, including area code:

(414) 765-1107

 

Date of fiscal year end: December 31, 2009

 

Date of reporting period: March 31, 2009





 

 

ITEM 1. SCHEDULE OF INVESTMENTS

Eagle Capital Growth Fund, Inc.
Portfolio of Investments (as of March 31, 2009) (unaudited)

Common Stock (98.2% of Total Investments)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Industry

 

 

Shares

 

Cost

 

Market Value

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consumer

 

 

 

 

 

 

 

 

 

 

 

 

Alcon Inc.

 

 

4,000

 

 

360,012

 

 

363,640

 

 

 

Colgate-Palmolive Co.

 

 

13,000

 

 

322,390

 

 

766,740

 

 

 

PepsiCo Inc.

 

 

10,000

 

 

168,296

 

 

514,800

 

 

 

 

 

 

 

 

 

 

 

   

 

 

 

 

 

 

 

 

 

 

 

$

1,645,180

 

(11.6

%)

Data Processing

 

 

 

 

 

 

 

 

 

 

 

 

Automatic Data Processing, Inc.

 

 

12,000

 

 

417,172

 

 

421,920

 

 

 

Jack Henry & Associates Inc.

 

 

34,000

 

 

626,877

 

 

554,880

 

 

 

Metavante Technologies, Inc. *

 

 

1,666

 

 

43,292

 

 

33,253

 

 

 

Paychex Inc.

 

 

29,000

 

 

796,569

 

 

744,430

 

 

 

Total Systems Services, Inc.

 

 

13,065

 

 

177,851

 

 

180,428

 

 

 

 

 

 

 

 

 

 

 

   

 

 

 

 

 

 

 

 

 

 

 

$

1,934,911

 

(13.6

%)

Drug/Medical Device

 

 

 

 

 

 

 

 

 

 

 

 

Johnson & Johnson

 

 

17,000

 

 

731,295

 

 

894,200

 

 

 

Medtronic, Inc.

 

 

17,000

 

 

850,214

 

 

500,990

 

 

 

Pfizer Inc.

 

 

39,000

 

 

796,655

 

 

531,180

 

 

 

Stryker Corp.

 

 

22,000

 

 

180,012

 

 

748,880

 

 

 

Teleflex Inc.

 

 

16,000

 

 

545,608

 

 

625,440

 

 

 

Zimmer Holdings Inc. *

 

 

1,000

 

 

81,859

 

 

36,500

 

 

 

 

 

 

 

 

 

 

 

   

 

 

 

 

 

 

 

 

 

 

 

$

3,337,190

 

(23.5

%)

Bank

 

 

 

 

 

 

 

 

 

 

 

 

CIT Group, Inc.

 

 

20,000

 

 

587,335

 

 

57,000

 

 

 

Citigroup Inc.

 

 

22,000

 

 

368,636

 

 

55,660

 

 

 

Marshall & Ilsley Corp.

 

 

5,000

 

 

167,716

 

 

28,150

 

 

 

State Street Corp.

 

 

6,000

 

 

54,688

 

 

184,680

 

 

 

 

 

 

 

 

 

 

 

   

 

 

 

 

 

 

 

 

 

 

 

$

325,490

 

(2.3

%)

Industrial

 

 

 

 

 

 

 

 

 

 

 

 

Emerson Electric Co.

 

 

20,000

 

 

335,278

 

 

571,600

 

 

 

General Electric Co.

 

 

50,000

 

 

1,179,979

 

 

505,500

 

 

 

Graco Inc.

 

 

25,000

 

 

987,169

 

 

426,750

 

 

 

Manitowoc Company Inc.

 

 

65,000

 

 

1,269,708

 

 

212,550

 

 

 

Sigma Aldrich Corp.

 

 

7,000

 

 

58,094

 

 

264,530

 

 

 

 

 

 

 

 

 

 

 

   

 

 

 

 

 

 

 

 

 

 

 

$

1,980,930

 

(13.9

%)

Mutual Fund Managers

 

 

 

 

 

 

 

 

 

 

 

 

Eaton Vance Corp.

 

 

36,000

 

 

1,032,875

 

 

822,600

 

 

 

Franklin Resources Inc.

 

 

13,000

 

 

1,190,124

 

 

700,310

 

 

 

T. Rowe Price

 

 

19,000

 

 

633,571

 

 

548,340

 

 

 

 

 

 

 

 

 

 

 

   

 

 

 

 

 

 

 

 

 

 

 

$

2,071,250

 

(14.6

%)

Insurance

 

 

 

 

 

 

 

 

 

 

 

 

AFLAC Inc.

 

 

16,500

 

 

79,484

 

 

319,440

 

 

 

Berkshire Hathaway “B”*

 

 

200

 

 

751,847

 

 

564,000

 

 

 

 

 

 

 

 

 

 

 

   

 

 

 

 

 

 

 

 

 

 

 

$

883,440

 

(6.2

%)

Retail/Distribution

 

 

 

 

 

 

 

 

 

 

 

 

The Home Depot, Inc.

 

 

26,500

 

 

1,039,592

 

 

624,340

 

 

 

Lowe’s Companies Inc.

 

 

10,000

 

 

254,089

 

 

182,500

 

 

 

Sysco Corp.

 

 

27,000

 

 

309,199

 

 

615,600

 

 

 

 

 

 

 

 

 

 

 

   

 

 

 

 

 

 

 

 

 

 

 

$

1,422,440

 

(10.0

%)

Software

 

 

 

 

 

 

 

 

 

 

 

 

Microsoft Corporation

 

 

19,000

 

 

372,659

 

 

349,030

 

 

 

 

 

 

 

 

 

 

 

   

 

 

 

 

 

 

 

 

 

 

 

$

349,030

 

(2.5

%)

 

 

 

 

 

 

 

 

 

 

 

 

 

Total common stock investments

 

 

 

 

 

 

 

$

13,949,861

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents (1.8% of total investments)

 

 

 

 

 

 

 

 

256,266

 

 

 

 

 

 

 

 

 

 

 

   

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total investments

 

 

 

 

 

 

 

$

14,206,127

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

All other assets less liabilities

 

 

 

 

 

 

 

 

11,824

 

 

 

 

 

 

 

 

 

 

 

   

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total net assets

 

 

 

 

 

 

 

$

14,217,951

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

*Non-dividend paying security

 

 

 

 

 

 

 

 

 

 

 

 




Footnote:

The following information is based upon federal income tax cost of portfolio investments as of March 31, 2009:

 

 

 

 

 

Gross unrealized appreciation

 

$

2,732,520

 

Gross unrealized depreciation

 

 

(5,552,803

)

 

 

   

 

Net unrealized depreciation

 

$

(2,820,283

)

 

 

   

 

 

 

 

 

 

Federal income tax basis

 

$

16,770,145

 


 

 

ITEM 2. VALUATION HIERARCHY

SFAS 157 establishes a three-level valuation hierarchy for disclosure of fair value measurements. The valuation hierarchy is based upon the transparency of inputs to the valuation of an asset or liability as of the measurement date. The three levels are defined as follows:

          Level 1 – inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets in which the Fund can participate.

          Level 2 – inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset of liability, either directly or indirectly, for substantially the full term of the financial instrument.



          Level 3 – inputs to the valuation methodology are unobservable and significant to the fair value measurement, and include inputs that are available in situations where there is little, if any, market activity for the related asset or liability.

A financial instrument’s categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.

The following is a description of the valuation methodologies used for instruments measured at fair value, as well as the general classification of such instruments pursuant to the valuation hierarchy.

Assets

          Common Stock Investments

          All of the Fund’s common stock investments are classified within Level 1 of the valuation hierarchy as quoted prices are available in an active market.

          The following table presents the financial instruments carried at fair value as of March 31, 2009, as identified in Item 1., Schedule of Investments and by the SFAS 157 hierarchy (as described above):

          Assets measure at fair value on a recurring basis as of March 31, 2009:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Quoted Prices in
Active Markets
for Identical
Assets
Level 1

 

Significant
Other
Observable
Inputs
Level 2

 

Significant
Unobservable
Inputs
Level 3

 

Balance at
September 30,
2008

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common Stock Investments

 

 

$

13,949,861

 

 

 

$

 

 

 

$

 

 

 

$

13,949,861

 

 


 

 

ITEM 3.

CONTROLS AND PROCEDURES.

     (i) As of April 1, 2009, an evaluation of the effectiveness of the registrant’s disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) was performed by management with the participation of the registrant’s President and Chief Executive Officer (who is the principal executive officer of the registrant) and the registrant’s Chief Financial Officer (who is the principal financial officer of the registrant). Based on that evaluation, the registrant’s President and Chief Executive Officer and Chief Financial Officer concluded that the registrant’s disclosure controls and procedures are effectively designed to ensure that information required to be disclosed by the registrant is recorded, processed, summarized and reported within the time periods specified by the Commission’s rules and forms, and that information required to be disclosed by the registrant has been accumulated and communicated to the registrant’s management, including its principal executive officer and principal financial officer, or persons performing similar functions as appropriate to allow timely decisions regarding required disclosure.



     (ii) There has been no change in the registrant’s internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act) that occurred during the last fiscal quarter of the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

 

 

ITEM 3.

EXHIBITS


 

 

99.1

Certification of principal executive officer as required by Rule 30a-2(a) under the Act.

 

 

99.2

Certification of principal financial officer as required by Rule 30a-2(a) under the Act.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

EAGLE CAPITAL GROWTH FUND, INC.

 

 

By:

/s/ Luke E. Sims

 

 

Luke E. Sims

 

President and Chief Executive Officer

 

 

Dated: April 8, 2009

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

 

By:

/s/ Luke E. Sims

 

 

Luke E. Sims

 

President and Chief Executive Officer (Principal Executive Officer)

 

 

Dated: April 8, 2009

 

 

By:

/s/ David C. Sims

 

 

David C. Sims

 

Chief Financial Officer (Principal Financial Officer)

 

 

Date: April 8, 2009